Feasibility of prior administration of cyclophosphamide in TC combination treatment

Author： Abe Hajime   Kawai Yuki   Mori Tsuyoshi   Cho Hirotomi   Kubota Yoshihiro   Umeda Tomoko   Tani Tohru  

Publisher： Springer Publishing Company

ISSN： 1340-6868

Source： Breast Cancer, Vol.21, Iss.2, 2014-03, pp. : 202-207

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Vincristine, cisplatin, teniposide, and cyclophosphamide combination in the treatment of recurrent or metastatic adrenocortical cancer

By Khan Tanweera   Sundin Anders   Juhlin Claes   Wilander Erik   Öberg Kjell   Eriksson Barbro  

Medical Oncology, Vol. 21, Iss. 2, 2004-06 ,pp. : 167-177

Humana Press, Inc

Access to resources Recommend Favorite

Feasibility study of oral cyclophosphamide salvage therapy for the treatment of heavily pretreated patients with recurrent epithelial ovarian cancer

By Watanabe Yoh   Etoh Tomomaro   Koike Eiji   Mizuno Yoshiaki   Wang Wei-Min   Hoshiai Hiroshi  

International Journal of Clinical Oncology, Vol. 15, Iss. 5, 2010-10 ,pp. : 468-471

Springer Publishing Company

Access to resources Recommend Favorite

Effectiveness of novel combination chemotherapy, consisting of 5-fluorouracil, vincristine, cyclophosphamide and etoposide, in the treatment of low-grade gliomas in children

By Lee Mee   Ra Young   Park Jun   Goo Hyun   Ahn Seung   Khang Shin   Song Joon   Kim Yoon   Ghim Thad  

Journal of Neuro-Oncology, Vol. 80, Iss. 3, 2006-12 ,pp. : 277-284

Springer Publishing Company

Access to resources Recommend Favorite

A Phase II Multicenter Study of Two Different Dosages of Pemetrexed Given in Combination With Cyclophosphamide as First-Line Treatment in Patients With Locally Advanced or Metastatic Breast Cancer

By Dittrich Christian   Solska Ewa   Manikhas Alexey   Eniu Alexandru   Tjulandin Sergei   Anghel Rodica   Musib Luna   Frimodt-Moller Bente   Liu Yushan   Krejcy Kurt   Láng István  

Cancer Investigation, Vol. 30, Iss. 4, 2012-04 ,pp. : 309-316

Informa Healthcare

Access to resources Recommend Favorite

The Feasibility of Using Glycosylated Recombinant Human Granulocyte Colony-stimulating Factor (G-CSF) to Increase the Planned Dose Intensity of Doxorubicin, Cyclophosphamide and Etoposide (ACE) in the Treatment of Small Cell Lung Cancer

By Thatcher N.   Anderson H.   Bleehen N.M.   Girling D.J.   Lallemand G.   Machin D.   Stephens R.J.  

European Journal of Cancer, Vol. 31, Iss. 2, 1995-01 ,pp. : 152-156

Elsevier

Access to resources Recommend Favorite